Quoin Pharmaceuticals, Ltd. - American Depositary Shares QNRX 深 滬
已收盤 12-12 16:00:00 美东时间
10.30
-1.060
-9.33%
華盛通- 最 高11.8399
- 今 開11.29
- 成交量 4.20万股
- 最 低 10.08
- 昨 收 11.36
- 總市值 5201.21万
- 52周最高 41.80
- 市盈率 靜 --
- 換手率 0.83%
- 52周最低 5.01
- 委 比 -33.33%
- 總股本 504.97万
- 歷史最高 1417500.00
- 量 比 0.18
- 振 幅 15.49%
- 歷史最低 5.824
- 每 手 1
- 風險率 4.90%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Akanda (NASDAQ:AKAN) stock rose 28.9% to $1.22 during Friday's pre-mar...
12-05 20:05
Quoin Pharmaceuticals Q3 EPS $(6.71) Misses $(6.50) Estimate
Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(6.71) per share which missed the analyst consensus estimate of $(6.50) by 3.15 percent. This is a 59.21 percent increase over losses of $(16.45) per
11-06 21:34
Earnings Scheduled For November 6, 2025
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
Quoin Pharmaceuticals Announces Recruitment Of Three Additional Pediatric Patients For Its Investigator-Led Netherton Syndrome Study And Reports 9-month Results From The First Patient Treated With QRX003 Showing Completely Healed Skin After 9 Months Of 'Whole Body' Treatment
Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) (the "Company" or "Quoin"), a late clinical stage, specialty pharmaceutical company focused on the development and commercialization of therapeutic products that treat rare and
10-28 20:34
Quoin Pharmaceuticals Announces Recruitment of Three Additional Patients in Investigator Pediatric Netherton Syndrome Study and Provides Positive 9 month ‘Whole Body’ Data Update from Ongoing Study
Quoin Pharmaceuticals Ltd. announces the recruitment of three additional pediatric patients in its Netherton Syndrome (NS) study and reports positive 9-month clinical data from the first pediatric patient. The patient experienced complete skin healing, with IGA improving from 4 (severe) to 0 (clear), and pruritus reduced from 5 to 0. No adverse events were reported after 9 months of QRX003 treatment. The patient no longer requires medications lik...
10-28 12:30
Why NioCorp Developments Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Shares of NioCorp Developments Ltd (NASDAQ:NB) rose sharply in pre-market tradi...
10-13 17:26
Here’s Why Quoin Pharmaceuticals Stock (QNRX) Exploded Today
Quoin Pharmaceuticals ($QNRX) stock skyrocketed by about 157% on Friday after a...
10-11 03:05
Quoin Pharmaceuticals (QNRX) Stock Is Skyrocketing Friday: What's Going On?
Quoin Pharmaceuticals shares are trading higher Friday morning after the company announced a private placement financing of up to $104.5 million.
10-11 00:31
Quoin Pharmaceuticals shares are trading higher. The company announced a $104.5 million private placement.
Quoin Pharmaceuticals shares are trading higher. The company announced a $104.5...
10-10 21:34
